Sales & Marketing Creative review: The Cannes Lions trends that pharma needs t... Pharma creative needs to stand up and be counted.
News Rebranded Servier eyes €3bn in cancer drug sales by 2030 Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category.
Views & Analysis 4 tips on how to navigate ‘global versus local’ challenges i... How to communicate a pharma brand identity and new product successfully, both globally and locally.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
